共 318 条
[31]
Ramsay AJ(2006)Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells J Immunol 177 1021-1609
[32]
Ertl HC(2005)The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis Infect Immun 73 831-1752
[33]
Nakanishi M(2013)Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial Lancet 381 46-564
[34]
Otsu M(2016)Pulmonary but not subcutaneous delivery of BCG vaccine confers protection to tuberculosis-susceptible mice by an interleukin 17-dependent mechanism J Infect Dis 213 1602-493
[35]
Le TV(2017)Variable BCG efficacy in rhesus populations: pulmonary BCG provides protection where standard intra-dermal vaccination fails Tuberculosis (Edinb) 104 1743-241
[36]
Mironova E(2003)Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of Bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara J Immunol 171 555-661
[37]
Garcin D(2018)Pulmonary immunization with a recombinant influenza A virus vaccine induces lung-resident CD4(+) memory T cells that are associated with protection against tuberculosis Mucosal Immunol 11 483-274
[38]
Compans RW(2019)Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1(+) KLRG1(-) CD4(+) T cells Mucosal Immunol 12 233-212
[39]
Zhang X(2003)Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis Infect Immun 71 648-1534
[40]
Sobue T(2006)Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration FEMS Immunol Med Microbiol 47 272-3776